Ontario-based WeedMD is expanding its reach to Atlantic Canada with the hiring of New Brunswick-based physician, Dr. Julie Hildebrand.
Hildebrand is recognized in the region for specializing in cannabis medicine and education. She will work with patients and benefits providers in New Brunswick, Nova Scotia, Prince Edward Island and Newfoundland, providing WeedMD’s Starseed Medicinal products and its North Star Virtual Patient Care Program.
“The Atlantic region’s healthcare system is overburdened with opioid addiction and the need for alternate therapies. Dr. Hildebrand will provide extended assessments to patients seeking standardized treatment and dosing options, as well as a platform to assist patients if their primary care providers are unavailable,” said Dr. Peter Blecher, WeedMD’s chief medical officer.
Hildebrand has more than 30 years of biomedical research and medical experience. She has published more than 40 communications, papers and publications on cannabis medicine as a new therapy, effects of opioid addiction, methadone treatment analysis, mental health and addiction.
She is also the medical director of the Methadone Maintenance Therapy Program at Saint Joseph’s Hospital in Saint John, NB.
“Physicians have a responsibility to carefully assess and educate patients on treatment options that may be most effective to improve their health and quality of life. It’s our duty to become well-informed and counsel patients on all available medicines and treatments that can provide the highest level of care,” said Dr. Hildebrand.
WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The company owns and operates a 158-acre, greenhouse, outdoor and processing facility located in Strathroy, Ont., as well as a fully-licensed 26,000 sq. ft. processing facility in Aylmer, Ont. which specializes in cannabis extraction.
Print this page